Boehringer Ingelheim (United States)
In research, Boehringer Ingelheim (United States) stands highest in Health Sciences (#4,660 of 11,982 worldwide), Medicine (#4,191 of 10,443 worldwide) and Life Sciences (#3,730 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Immunology — Immunology is 7.8× its share of world research.
- World rank, 2022–2025
- #6,723 of 28,054 · #3,362 all time
- Rank in United States
- #895 of 4,192
- Research works
- 2.1k ▼ 2% vs 2013–17
- Citations
- 65k 31.2 per fractional work
- Top-10% rate
- 12.2% record average 16.5%
- Open access
- 34% world 28%
What is Boehringer Ingelheim (United States) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Health SciencesDomain | #4,660 of 11,982 | 13.4% | 179 | #1841 | |
| MedicineField | #4,191 of 10,443 | 13.7% | 162 | #1479 | |
| Life SciencesDomain | #3,730 of 7,800 | 12.6% | 106 | #2321 | |
| Physical SciencesDomain | #8,741 of 12,888 | 9.8% | 69 | #4575 |
Each strip is that field’s whole ranked pool, with the notch where Boehringer Ingelheim (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Health Sciences#1,841 #4,660
- Medicine#1,479 #4,191
- Life Sciences#2,321 #3,730
- Physical Sciences#4,575 #8,741
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Boehringer Ingelheim (United States) specialise in?
Where its research is concentrated relative to its size: Immunology takes 7.8× the share of its output that it takes of world research.
- ImmunologySubfield · 20.1 works7.8×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 20.0×. Every wedge is a field page.
- Veterinary 20.0×
- Pharmacology, Toxicology and Pharmaceutics 7.3×
- Immunology and Microbiology 6.9×
- Chemistry 6.2×
- Medicine 2.3×
- Biochemistry, Genetics and Molecular Biology 2.2×
- Agricultural and Biological Sciences 1.4×
- Chemical Engineering 1.3×
- Mathematics 1.1×
- Economics, Econometrics and Finance 1.1×
- Psychology 0.5×
- Materials Science 0.5×
- Nursing 0.5×
- Decision Sciences 0.5×
- Health Professions 0.5×
- Dentistry 0.4×
- Neuroscience 0.3×
- Environmental Science 0.3×
- Energy 0.2×
- Computer Science 0.1×
- Engineering 0.1×
- Arts and Humanities 0.1×
- Business, Management and Accounting 0.1×
- Earth and Planetary Sciences 0.1×
- Physics and Astronomy 0.0×
- Social Sciences 0.0×
Who are the top researchers at Boehringer Ingelheim (United States)?
Ranked on the composite score, Robert Rothlein, Steven Kesten and Sudha Visvanathan lead among researchers whose main affiliation is Boehringer Ingelheim (United States).
- 1 Robert Rothlein United States · #66,856 worldwide 416 citations · 28 works
- 2 Steven Kesten United States · #110,841 worldwide 188 citations · 27 works
- 3 Sudha Visvanathan United States · #147,392 worldwide 153 citations · 25 works
- 4 Chris H. Senanayake United States · #377,022 worldwide 296 citations · 76 works
- 5 Christine Grimaldi United States · #396,970 worldwide 91 citations · 21 works
- 6 Carl A. Busacca United States · #397,570 worldwide 83 citations · 23 works
- 7 Xingzhong Zeng United States · #476,316 worldwide 84 citations · 15 works
- 8 Nathan K. Yee United States · #504,247 worldwide 111 citations · 30 works
- 9 Nelu Grinberg United States · #579,807 worldwide 66 citations · 30 works
- 10 Magnus Eriksson United States · #739,547 worldwide 65 citations · 67 works
Which keywords describe research at Boehringer Ingelheim (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Fibrosis, TGF-ß, Epidemiology, Interstitial Lung Disease, Epithelial-Mesenchymal Transition, Idiopathic Pulmonary Fibrosis, Myofibroblast and Monoclonal Antibodies.
- Ivermectin
- Vaccine Development
- Immune System
- Gas Chromatography
- TGF-ß Signaling
- Insulin Therapy
- Antimicrobial Resistance
- Biopharmaceuticals
- Endothelial Dysfunction
- Therapeutic Antibodies
- Chronic Kidney Disease
- Clinical Guidelines
- Pathogenesis
- Autoantibodies
- Monoclonal Antibodies
- Myofibroblast
- Epithelial-Mesenchymal Transition
- Interstitial Lung Disease
- Inflammation
- Fibrosis
- Epidemiology
- TGF-ß
- Cardiovascular Disease
- Treatment
- Idiopathic Pulmonary Fibrosis
- Diagnosis
- Global Burden
- Heart Failure
- Genetics
- Liquid Chromatography
- Immunosuppressive Therapy
- Glycemic Control
- Glycosylation
- Medicinal Chemistry
- Chirality
- Pharmacokinetics
- Chiral Separation
- Immunogenicity
- Method Validation
- Genetic Markers
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology36▲ 2.4×64 topics
- Fibrosis23▲ 33×6 topics
- TGF-ß23▲ 40×4 topics
- Inflammation18▲ 2.4×43 topics
- Cardiovascular Disease14▲ 3.4×14 topics
- Interstitial Lung Disease14▲ 60×2 topics
- Treatment14▲ 3.1×19 topics
- Epithelial-Mesenchymal Transition13▲ 38×2 topics
- Idiopathic Pulmonary Fibrosis13▲ 76×1 topic
- Myofibroblast13▲ 76×1 topic
- Diagnosis13▲ 3.6×20 topics
- Monoclonal Antibodies12▲ 36×3 topics
- Global Burden12▲ 5.9×9 topics
- Autoantibodies10▲ 12×6 topics
- Heart Failure10▲ 6.3×9 topics
- Pathogenesis10▲ 5.3×12 topics
- Genetics9▲ 3.5×10 topics
- Clinical Guidelines9▲ 8.4×6 topics
- Liquid Chromatography9▲ 38×2 topics
- Chronic Kidney Disease8▲ 9.3×7 topics
- Immunosuppressive Therapy8▲ 12×6 topics
- Therapeutic Antibodies8▲ 31×2 topics
- Glycemic Control8▲ 14×4 topics
- Endothelial Dysfunction8▲ 8.8×6 topics
- Glycosylation8▲ 18×3 topics
- Biopharmaceuticals8▲ 39×3 topics
- Medicinal Chemistry8▲ 7.2×7 topics
- Antimicrobial Resistance7▲ 10.0×7 topics
- Chirality7▲ 32×2 topics
- Insulin Therapy7▲ 16×3 topics
- Pharmacokinetics7▲ 7.4×6 topics
- TGF-ß Signaling7▲ 31×3 topics
- Chiral Separation7▲ 42×1 topic
- Gas Chromatography7▲ 42×1 topic
- Immunogenicity7▲ 44×2 topics
- Immune System7▲ 7.8×5 topics
- Method Validation7▲ 33×2 topics
- Vaccine Development6▲ 6.8×9 topics
- Genetic Markers6▲ 36×2 topics
- Ivermectin6▲ 60×2 topics
Which research topics does Boehringer Ingelheim (United States) publish most on?
By volume in 2022–2025: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Analytical Chemistry and Chromatography, Systemic Sclerosis and Related Diseases and Diabetes Treatment and Management.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 13 works
- 2 Analytical Chemistry and Chromatography Spectroscopy 7 works
- 3 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 6 works
- 4 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 6 works
- 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 5 works
- 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 5 works
- 7 Analytical Methods in Pharmaceuticals Analytical Chemistry 5 works
- 8 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 5 works
- 9 Helminth infection and control Small Animals 4 works
- 10 Psoriasis: Treatment and Pathogenesis Immunology 4 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Boehringer Ingelheim (United States)'s research output changed?
Output in 2018–2022 was 2% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Ridgefield
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.